拉坦前列素引起的过敏性接触性皮炎

Kelly Michele Jerstad, Erin Warshaw
{"title":"拉坦前列素引起的过敏性接触性皮炎","authors":"Kelly Michele Jerstad,&nbsp;Erin Warshaw","doi":"10.1053/ajcd.2002.30720","DOIUrl":null,"url":null,"abstract":"<div><p>An 85-year-old male with glaucoma presented with a 1-[frac12] year history of tearing; red eyes; and pruritic, edematous, eczematous eyelids. Treatment for presumed ocular rosacea and seborrhea was unhelpful. Patch testing to our standard 64 antigens yielded a positive reaction to Balsam of Peru. Notably, benzalkonium chloride, thimerosal, and other preservatives elicited negative reactions. Repeat open application testing elicited positive results to Xalatan (latanoprost) 0.005% ophthalmic solution (Pharmacia [amp ] Upjohn, Kalamazoo, MI). A second session of patch tests to 10 personal products, in addition to Xalatan 0.005% solution and the Xalatan vehicle (provided by the manufacturer), elicited a strong positive reaction only to the full preparation of Xalatan 0.005% solution. This report describes the first known case of ACD to latanoprost, a new prostaglandin analog that is widely prescribed for treatment of glaucoma.</p></div>","PeriodicalId":7653,"journal":{"name":"American Journal of Contact Dermatitis","volume":"13 1","pages":"Pages 39-41"},"PeriodicalIF":0.0000,"publicationDate":"2002-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1053/ajcd.2002.30720","citationCount":"30","resultStr":"{\"title\":\"Allergic contact dermatitis to latanoprost\",\"authors\":\"Kelly Michele Jerstad,&nbsp;Erin Warshaw\",\"doi\":\"10.1053/ajcd.2002.30720\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>An 85-year-old male with glaucoma presented with a 1-[frac12] year history of tearing; red eyes; and pruritic, edematous, eczematous eyelids. Treatment for presumed ocular rosacea and seborrhea was unhelpful. Patch testing to our standard 64 antigens yielded a positive reaction to Balsam of Peru. Notably, benzalkonium chloride, thimerosal, and other preservatives elicited negative reactions. Repeat open application testing elicited positive results to Xalatan (latanoprost) 0.005% ophthalmic solution (Pharmacia [amp ] Upjohn, Kalamazoo, MI). A second session of patch tests to 10 personal products, in addition to Xalatan 0.005% solution and the Xalatan vehicle (provided by the manufacturer), elicited a strong positive reaction only to the full preparation of Xalatan 0.005% solution. This report describes the first known case of ACD to latanoprost, a new prostaglandin analog that is widely prescribed for treatment of glaucoma.</p></div>\",\"PeriodicalId\":7653,\"journal\":{\"name\":\"American Journal of Contact Dermatitis\",\"volume\":\"13 1\",\"pages\":\"Pages 39-41\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1053/ajcd.2002.30720\",\"citationCount\":\"30\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Contact Dermatitis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1046199X02336121\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Contact Dermatitis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1046199X02336121","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 30

摘要

一例85岁男性青光眼患者,有1-[frac12]年的流泪史;红色的眼睛;以及眼睑瘙痒、水肿、湿疹。对假定的眼红斑痤疮和脂溢症的治疗无效。对64种标准抗原的斑贴试验对秘鲁香脂有阳性反应。值得注意的是,苯扎氯铵、硫柳汞和其他防腐剂引起了负面反应。重复开放应用试验得出0.005% Xalatan (latanoprost)眼科溶液(Pharmacia [amp] Upjohn, Kalamazoo, MI)阳性结果。除了Xalatan 0.005%溶液和Xalatan车辆(由制造商提供)外,对10种个人产品进行了第二次斑贴试验,仅对完全配制的Xalatan 0.005%溶液产生了强烈的积极反应。本报告描述了首例已知的拉坦前列素ACD病例,拉坦前列素是一种新的前列腺素类似物,广泛用于治疗青光眼。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Allergic contact dermatitis to latanoprost

An 85-year-old male with glaucoma presented with a 1-[frac12] year history of tearing; red eyes; and pruritic, edematous, eczematous eyelids. Treatment for presumed ocular rosacea and seborrhea was unhelpful. Patch testing to our standard 64 antigens yielded a positive reaction to Balsam of Peru. Notably, benzalkonium chloride, thimerosal, and other preservatives elicited negative reactions. Repeat open application testing elicited positive results to Xalatan (latanoprost) 0.005% ophthalmic solution (Pharmacia [amp ] Upjohn, Kalamazoo, MI). A second session of patch tests to 10 personal products, in addition to Xalatan 0.005% solution and the Xalatan vehicle (provided by the manufacturer), elicited a strong positive reaction only to the full preparation of Xalatan 0.005% solution. This report describes the first known case of ACD to latanoprost, a new prostaglandin analog that is widely prescribed for treatment of glaucoma.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
ALLERGIC CONTACT DERMATITIS OF THE FEET LONG-TERM STUDY ON PRIMARY PREVENTION OF IRRITANT CONTACT DERMATITIS A REVIEW OF PATCH TESTING WITH PRESERVATIVES AT ST. JOHNʼS INSTITUTE OF DERMATOLOGY FROM 1995 TO 2000 CONTACT ALLERGY TO METAL AND TOTAL JOINT ARTHROPLASTY QUALITY OF LIFE ANALYSIS IN PATIENTS WITH HAND DERMATITIS
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1